Plain-English translation of NCT06547710 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether surgically removing the primary (main) lung tumor can help patients with a specific type of advanced lung cancer — one that has spread to the pleura (the thin lining around the lungs) — improve their survival and quality of life. Researchers discovered during surgery that some patients have this hidden spread, and they want to understand if removing the main tumor anyway gives these patients real benefits.
Currently, doctors are uncertain whether operating to remove the main tumor helps patients whose cancer has already spread to the lung lining. This study aims to answer that question so doctors can make better treatment decisions for patients in this situation.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo surgery to have your main lung tumor removed. After surgery, doctors will monitor you closely to track how you recover and how your cancer responds. The study will follow your health and quality of life over time to see whether removing the tumor helped you live longer and feel better.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China
Enrollment target
~66 participants
Started
April 2024
Primary completion
December 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fangqiu Fu, MD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.